Atea Pharmaceuticals
Latest round
- Series D
Last raised
- May 2020
Total raised
- $128M
Investors
- 13
About Atea Pharmaceuticals
Based in the US, Atea Pharmaceuticals, Inc.Atea Pharmaceuticals specializes in the development of antiviral therapies and was founded in 2012 in Boston, US, by Jean-Pierre Sommadossi, who has a history of founding other biotech firms.Atea Pharmaceuticals specializes in developing innovative oral antiviral therapeutics, primarily targeting serious viral diseases such as hepatitis C virus (HCV). The company’s lead product regimen combines bemnifosbuvir, a nucleotide analog polymerase inhibitor, with ruzasvir, an NS5A inhibitor. This dual therapy aims to offer a potent, pan-genotypic antiviral solution, characterized by a short treatment duration and low risk of drug-drug interactions., Canada, and other international markets.53 mn for the same year. The company generates revenue through strategic partnerships and collaborations focused on the development and commercialization of its antiviral therapies, engaging in business-to-business transactions with pharmaceutical distributors and healthcare institutions. The company is targeting expansion into additional global markets, focusing on regions where hepatitis C remains prevalent. Specific timelines for new product launches and market entry strategies are being developed as Atea continues to innovate in the antiviral therapeutic space.
Who invested in Atea Pharmaceuticals
13 investors across 2 rounds
See all investors in Atea Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Atea Pharmaceuticals
Who invested in Atea Pharmaceuticals?
Atea Pharmaceuticals has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Atea Pharmaceuticals raised?
Atea Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Atea Pharmaceuticals last raise money?
Atea Pharmaceuticals's most recent round on record is a Series D, in May 2020.
What does Atea Pharmaceuticals do?
Based in the US, Atea Pharmaceuticals, Inc.
Where is Atea Pharmaceuticals headquartered?
Atea Pharmaceuticals is headquartered in Boston, US.
Which VCs invest in companies like Atea Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Atea Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Atea Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.